Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the ...

Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.

Gene editing in the womb could be more effective than the same treatment after birth, as it is easier to deliver the ...

Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.

Researchers used mitochondrial gene editing to model genetic disorders in mice, revealing profound impacts on brain function, ...

ToolGen, a leading gene editing company, and PlantArcBio (TASE: PLNT), a leading ag-biotech company specializing in gene discovery and biological components to enhance agricultural crop traits, ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...

Financially, Verve has a market cap of $475mn, cash balance of $540mn, and a cash runway of 7-8 quarters. Find out my ...